A new era for treating high-risk neuroblastoma – research advances to look out for in 2024
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed...
May 16, 2024
FDA approves tovorafenib for most common form of childhood brain tumor
This decision from the federal agency marks the first FDA approval of a systemic therapy to treat patients with pediatric LGG with BRAF...
May 15, 2024
‘Kinder’ treatment for childhood brain cancer to be offered by NHS in England
Dabrafenib with trametinib can halt growth of some tumours for more than three times as long as standard chemotherapy, study shows. Read...
May 14, 2024
New findings regarding diabetes risk in childhood cancer survivors
Researchers at St. Jude Children’s Research Hospital have identified four previously unknown genetic variants associated with diabetes...
May 13, 2024
What it’s like to be a ‘glass child’
In many families, parents or guardians can be so consumed with caring for a special needs child that their other children often respond...
May 10, 2024
Childhood cancer survivors face ‘numerous socioeconomic challenges’
Researchers found childhood cancer survivors had higher odds of health-related unemployment, in addition to being less likely to complete...
May 9, 2024
Groundbreaking treatment approach shows promise in hard-to-treat cancers
Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with a new way to...
May 8, 2024
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies
Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatments...
May 7, 2024
PET/MRI detects brain injury in pediatric cancer survivors
PET/MRI could be a tool for diagnosing brain injury in young cancer survivors due to high-dose methotrexate treatment, according to...
May 6, 2024
Targeting vulnerability in B-cell development leads to novel drug combination for leukemia
By characterizing B-cells’ developmental stages, scientists at St. Jude Children’s Research Hospital designed and tested a drug...
May 3, 2024